Overview
Theodore Braun is an Oncologist in Portland, Oregon. Dr. Braun is rated as a Distinguished provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Leukemia, and Chronic Myelomonocytic Leukemia (CMML). Dr. Braun is currently accepting new patients.
His clinical research consists of co-authoring 41 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Chronic Myelogenous Leukemia (CML).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- PPO
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3181 Sw Sam Jackson Park Rd, Portland, OR 97239
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Professional Services
Brian Druker is a Hematologist Oncology specialist and an Oncologist in Beaverton, Oregon. Dr. Druker is rated as an Elite provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Chronic Myelogenous Leukemia (CML), Leukemia, Acute Myeloid Leukemia (AML), and Philadelphia-Negative Chronic Myeloid Leukemia. Dr. Druker is currently accepting new patients.
University Professional Services
Michael Heinrich is a Hematologist Oncology specialist and a Hematologist in Portland, Oregon. Dr. Heinrich is rated as an Elite provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Gastrointestinal Stromal Tumor, Chronic Myelogenous Leukemia (CML), Undifferentiated Pleomorphic Sarcoma, and Mesenchymoma. Dr. Heinrich is currently accepting new patients.
University Professional Services
Onyekachi Ogbonna is an Oncologist and a Hematologist Oncology provider in Portland, Oregon. Dr. Ogbonna is rated as an Advanced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Childhood Iron Deficiency Anemia, Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, and Childhood Acute Myeloid Leukemia. Dr. Ogbonna is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Myelogenous Leukemia (CML)Dr. Braun isDistinguished. Learn about Chronic Myelogenous Leukemia (CML).
- Advanced
- Chronic Myelomonocytic Leukemia (CMML)
- LeukemiaDr. Braun isAdvanced. Learn about Leukemia.
- Philadelphia-Negative Chronic Myeloid Leukemia
- Experienced
- Acute Myeloid Leukemia (AML)Dr. Braun isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Childhood Acute Myeloid LeukemiaDr. Braun isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Myelodysplastic Syndrome (MDS)Dr. Braun isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- Myeloproliferative Neoplasms (MPN)Dr. Braun isExperienced. Learn about Myeloproliferative Neoplasms (MPN).